Karin Jöhrer

Years Active: 2019-2022
Publications (10 Years): 5

Tyrolean Cancer Research Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Tyrolean Cancer Research Institute Apr 01 2000

Austria

Head of Institute, Group leader

Publications

Karin Jöhrer, Mayra Galarza Pérez, Brigitte Kircher, Serhat Sezai Çiçek
Flavones, Flavonols, Lignans, and Caffeic Acid Derivatives from Dracocephalum moldavica and Their In Vitro Effects on Multiple Myeloma and Acute Myeloid Leukemia. International journal of molecular sciences 23 (22) (2022)
Maria Orfanoudaki, Anja Hartmann, Mostafa Alilou, Naida Mehic, Marcel Kwiatkowski, Karin Jöhrer, Huu Tung Nguyen, Andreas Hensel, Richard Greil, Markus Ganzera
Cytotoxic Compounds of Two Demosponges (Aplysina aerophoba and Spongia sp.) from the Aegean Sea. Biomolecules 11 (5) (2021)
Karin Jöhrer, Serhat Sezai Çiçek
Multiple Myeloma Inhibitory Activity of Plant Natural Products. Cancers 13 (11) (2021)
Normann Steiner, Karin Jöhrer, Selina Plewan, Andrea Brunner-Véber, Georg Göbel, David Nachbaur, Dominik Wolf, Eberhard Gunsilius, Gerold Untergasser
The FMS like Tyrosine Kinase 3 (FLT3) Is Overexpressed in a Subgroup of Multiple Myeloma Patients with Inferior Prognosis. Cancers 12 (9) (2020)
Johanna Willer, Karin Jöhrer, Richard Greil, Christian Zidorn, Serhat Sezai Çiçek
Cytotoxic Properties of Damiana (Turnera diffusa) Extracts and Constituents and A Validated Quantitative UHPLC-DAD Assay. Molecules (Basel, Switzerland) 24 (5) (2019)

Karin Jöhrer.css-eqlu8i{font-size:small;padding-left:4px;}